| Layton Psychology Pllc | |
|
23111 Interstate 30 S Bryant AR 72022-2570 | |
| (501) 847-5040 | |
| (501) 847-5060 |
| Full Name | Layton Psychology Pllc |
|---|---|
| Speciality | Psychologist |
| Location | 23111 Interstate 30 S, Bryant, Arkansas |
| Authorized Official Name and Position | Haley Layton (OWNER) |
| Authorized Official Contact | 8702437292 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Layton Psychology Pllc 4601 Summit Ridge Dr Jonesboro AR 72404-9101 Ph: (870) 243-7292 | Layton Psychology Pllc 23111 Interstate 30 S Bryant AR 72022-2570 Ph: (501) 847-5040 |
| NPI Number | 1962274449 |
|---|---|
| Provider Enumeration Date | 10/26/2023 |
| Last Update Date | 11/19/2023 |
| Certification Date | 11/19/2023 |
| Medicare PECOS PAC ID | 1850744046 |
|---|---|
| Medicare Enrollment ID | O20240124000856 |
News Archive
The 2014 DIA patient fellows illustrate the power of patient advocacy. A Parkinson's disease patient is the driving force in the success of clinical trials, recruiting patients and transporting them to research sites while saving researchers thousands of dollars.
Scientists in the Britain say hospitals could be facing an increasing threat from yet another deadly bacterial infection with the potential to rapidly develop a resistance to drugs.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
Researchers at UT Southwestern Medical Center have determined that the level, or saturation, of oxygen in blood could be used to identify children with sickle cell anemia who are at an increased risk of stroke.
Bloomberg BusinessWeek: The health overhaul legislation will likely cost drugmakers $25 billion more than the $80 billion the industry anticipated when it agreed to back the Democratic-led effort, according to Wall Street analysts. "The extra costs will come from expanding drug rebates through Medicaid, the U.S. insurance program for the poor, [Leerink Swann & Co executive] John L. Sullivan said today at a Bloomberg conference in Chicago."
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962274449 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Haley Kristin Layton |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1306573266 PECOS PAC ID: 5092189076 Enrollment ID: I20240124001666 |
News Archive
The 2014 DIA patient fellows illustrate the power of patient advocacy. A Parkinson's disease patient is the driving force in the success of clinical trials, recruiting patients and transporting them to research sites while saving researchers thousands of dollars.
Scientists in the Britain say hospitals could be facing an increasing threat from yet another deadly bacterial infection with the potential to rapidly develop a resistance to drugs.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
Researchers at UT Southwestern Medical Center have determined that the level, or saturation, of oxygen in blood could be used to identify children with sickle cell anemia who are at an increased risk of stroke.
Bloomberg BusinessWeek: The health overhaul legislation will likely cost drugmakers $25 billion more than the $80 billion the industry anticipated when it agreed to back the Democratic-led effort, according to Wall Street analysts. "The extra costs will come from expanding drug rebates through Medicaid, the U.S. insurance program for the poor, [Leerink Swann & Co executive] John L. Sullivan said today at a Bloomberg conference in Chicago."
› Verified 8 days ago
News Archive
The 2014 DIA patient fellows illustrate the power of patient advocacy. A Parkinson's disease patient is the driving force in the success of clinical trials, recruiting patients and transporting them to research sites while saving researchers thousands of dollars.
Scientists in the Britain say hospitals could be facing an increasing threat from yet another deadly bacterial infection with the potential to rapidly develop a resistance to drugs.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
Researchers at UT Southwestern Medical Center have determined that the level, or saturation, of oxygen in blood could be used to identify children with sickle cell anemia who are at an increased risk of stroke.
Bloomberg BusinessWeek: The health overhaul legislation will likely cost drugmakers $25 billion more than the $80 billion the industry anticipated when it agreed to back the Democratic-led effort, according to Wall Street analysts. "The extra costs will come from expanding drug rebates through Medicaid, the U.S. insurance program for the poor, [Leerink Swann & Co executive] John L. Sullivan said today at a Bloomberg conference in Chicago."
› Verified 8 days ago
Kristin N Kiernan Aprn Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 3348 Main St Ste 100, Bryant, AR 72022 Phone: 844-514-5183 | |
Win Within Therapy Group Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 207 Progress Way Ste 107, Bryant, AR 72022 Phone: 870-858-0303 Fax: 479-763-0030 | |
Balance Counselng & Consulting Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2213 N Reynolds Rd Ste 26, Bryant, AR 72022 Phone: 501-303-6108 | |
Autism In Motion Clinics, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 22461 I 30 Ste 1100b, Bryant, AR 72022 Phone: 404-935-8283 | |
Tasha Harris Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2213 N Reynolds Rd Ste 8, Bryant, AR 72022 Phone: 501-213-8408 | |
Livestrong, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 317 Dogwood Place Dr, Bryant, AR 72022 Phone: 501-722-2819 | |
Divine Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 209 Roya Ln Ste 4, Bryant, AR 72022 Phone: 501-213-1077 |